Urinary biomarkers of IgA nephropathy and other IgA-associated renal diseases

[1]  J. Klein,et al.  Urinary proteomics and biomarker discovery for glomerular diseases. , 2004, Contributions to nephrology.

[2]  Jeffrey S. Morris,et al.  Signal in noise: evaluating reported reproducibility of serum proteomic tests for ovarian cancer. , 2005, Journal of the National Cancer Institute.

[3]  M. Hardy,et al.  Disappearance of glomerular mesangial IgA deposits after renal allograft transplantation. , 1982, Transplantation.

[4]  D. Sène,et al.  Hepatitis C virus-associated B-cell proliferation--the role of serum B lymphocyte stimulator (BLyS/BAFF). , 2007, Rheumatology.

[5]  E. Haddad,et al.  Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. , 2004, Journal of the American Society of Nephrology : JASN.

[6]  M. Mir,et al.  Recurrence of IgA nephropathy and Henoch-Schönlein purpura after kidney transplantation: risk factors and graft survival. , 2005, Transplantation proceedings.

[7]  Jeffrey S. Morris,et al.  Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments , 2004, Bioinform..

[8]  J. Barratt,et al.  Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. , 2001, Kidney international.

[9]  H. Mischak,et al.  Proteomics: a novel tool to unravel the patho-physiology of uraemia. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  H. Rupprecht,et al.  Cell-matrix interactions in the glomerular mesangium. , 1996, Kidney international.

[11]  N. Kurumatani,et al.  Prognostic Value of Urinary Interleukin 6 in Patients with IgA Nephropathy: An 8-Year Follow-Up Study , 2002, Nephron.

[12]  M. Nakazawa.  [Circulating immune complexes in IgA nephropathy]. , 1982, Nihon Jinzo Gakkai shi.

[13]  B. Julian,et al.  Interactions of human mesangial cells with IgA and IgA-containing immune complexes. , 2002, Kidney international.

[14]  Mitsuaki Yanagida,et al.  Functional proteomics; current achievements. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[15]  J. Klein,et al.  Two-dimensional gel electrophoresis: a fundamental tool for expression proteomics studies. , 2004, Contributions to nephrology.

[16]  Chul-woo Yang,et al.  Establishment of a 2‐D human urinary proteomic map in IgA nephropathy , 2006, Proteomics.

[17]  A. Semjonow,et al.  Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine , 2005, Electrophoresis.

[18]  R. Star,et al.  Exosomal Fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury. , 2006, Kidney international.

[19]  J. Mestecky,et al.  Urinary IgA in IgA nephropathy and Henoch-Schoenlein purpura , 1985, Journal of Clinical Immunology.

[20]  N. Hotta,et al.  Complement activation products in the urine from proteinuric patients. , 1998, Journal of the American Society of Nephrology : JASN.

[21]  M. Lévy,et al.  Worldwide perspective of IgA nephropathy. , 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[22]  Thorsten Kaiser,et al.  Determination of peptides and proteins in human urine with capillary electrophoresis-mass spectrometry, a suitable tool for the establishment of new diagnostic markers. , 2003, Journal of chromatography. A.

[23]  B. Julian,et al.  IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. , 2005, Kidney international.

[24]  S. Goodman,et al.  Interactions between glomerular mesangial cells, cytokines, and extracellular matrix. , 1992, Journal of the American Society of Nephrology : JASN.

[25]  H. Mischak,et al.  Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy. , 2005, Kidney international.

[26]  H. Issaq,et al.  The role of separation science in proteomics research , 2001, Electrophoresis.

[27]  Thorsten Kaiser,et al.  Proteomic analysis for the assessment of diabetic renal damage in humans. , 2004, Clinical science.

[28]  H. Mischak,et al.  Biomarker discovery by CE‐MS enables sequence analysis via MS/MS with platform‐independent separation , 2006, Electrophoresis.

[29]  N. Yorioka,et al.  An immunohistochemical study of extracellular matrix components and integrins in human glomerular diseases. , 1994, Nihon Jinzo Gakkai shi.

[30]  R. Wyatt,et al.  Pediatric IgA nephropathies: clinical aspects and therapeutic approaches. , 2004, Seminars in nephrology.

[31]  Y. Kanno,et al.  Absence of Increased α1-Microglobulin in IgA Nephropathy Proteinuria* , 2007, Molecular & Cellular Proteomics.

[32]  Masaki Kobayashi,et al.  Natural history and risk factors for immunoglobulin a nephropathy in Japan , 1997 .

[33]  F. Scolari,et al.  Repetitive Fragmentation Products of Albumin and α1-Antitrypsin in Glomerular Diseases Associated with Nephrotic Syndrome , 2006 .

[34]  Tsuyoshi Watanabe,et al.  Risk factors for bleeding complications in percutaneous renal biopsy , 2005, Clinical and Experimental Nephrology.

[35]  H. Frierson,et al.  Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis. , 2006, The Lancet. Oncology.

[36]  A. Martini,et al.  IgA nephropathy and Henoch-Schonlein syndrome occurring in the same patient. , 1996, Nephron.

[37]  J. Berger,et al.  [Intercapillary deposits of IgA-IgG]. , 1968, Journal d'urologie et de nephrologie.

[38]  Walter Kolch,et al.  Discovery of biomarkers in human urine and cerebrospinal fluid by capillary electrophoresis coupled to mass spectrometry: Towards new diagnostic and therapeutic approaches , 2005, Electrophoresis.

[39]  A. Koyama,et al.  Natural history and risk factors for immunoglobulin A nephropathy in Japan. Research Group on Progressive Renal Diseases. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[40]  L. Gesualdo,et al.  Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: a pathogenetic role in interstitial monocytes recruitment. , 1996, Journal of the American Society of Nephrology : JASN.

[41]  R. Coppo,et al.  Aberrant glycosylation in IgA nephropathy (IgAN). , 2004, Kidney international.

[42]  J. Jennette.  The immunohistology of IgA nephropathy. , 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[43]  B. Julian,et al.  IgA-containing immune complexes in the urine of IgA nephropathy patients. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[44]  F. Lang,et al.  Potassium and Sodium Balance in U937 Cells During Apoptosis With and Without Cell Shrinkage , 2005, Cellular Physiology and Biochemistry.

[45]  Y. Kanno,et al.  Absence of increased alpha1-microglobulin in IgA nephropathy proteinuria. , 2007, Molecular & cellular proteomics : MCP.

[46]  Rong-Fong Shen,et al.  Identification and proteomic profiling of exosomes in human urine. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[47]  H. Mischak,et al.  Electrophoretic methods for analysis of urinary polypeptides in IgA‐associated renal diseases , 2007, Electrophoresis.

[48]  W. Kolch,et al.  Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery. , 2005, Mass spectrometry reviews.

[49]  X. Wang,et al.  Effect of Hepatitis C Virus Core Protein on the Molecular Profiling of Human B Lymphocytes , 2006, Molecular medicine.

[50]  N. Yoshikawa,et al.  Repeat renal biopsy in children with IgA nephropathy. , 1990, Clinical nephrology.

[51]  J. Squifflet,et al.  COURSE OF HENOCH‐SCHÖNLEIN NEPHRITIS AFTER RENAL TRANSPLANTATION: REPORT ON TEN PATIENTS AND REVIEW OF THE LITERATURE , 1994, Transplantation.

[52]  I. T. Ten Berge,et al.  What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis? , 2001, Kidney international.

[53]  G. D'Amico,et al.  Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[54]  M. Girolami,et al.  Clinical proteomics: A need to define the field and to begin to set adequate standards , 2007, Proteomics. Clinical applications.

[55]  B. Julian,et al.  Brief Communication: Glomerulonephritis in Patients with Hepatitis C Cirrhosis Undergoing Liver Transplantation , 2006, Annals of Internal Medicine.

[56]  V. Thongboonkerd,et al.  Urinary proteome profiling using microfluidic technology on a chip. , 2007, Journal of proteome research.

[57]  U. Berg,et al.  Henoch Schönlein nephritis: clinical findings related to renal function and morphology , 2004, Pediatric Nephrology.

[58]  L. Peruzzi,et al.  Glycosylation of circulating IgA in patients with IgA nephropathy modulates proliferation and apoptosis of mesangial cells. , 2001, Journal of the American Society of Nephrology : JASN.

[59]  F. Gejyo,et al.  Examination of the molecular diversity of α1 antitrypsin in urine: Deficit of an α1 globulin fraction on cellulose acetate membrane electrophoresis , 2005 .

[60]  R. Coppo,et al.  IgA serology in recurrent and non-recurrent IgA nephropathy after renal transplantation. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[61]  Y. Hiki,et al.  Application of mass spectrometry to IgA nephropathy: structural and biological analyses of underglycosylated IgA1 molecules. , 2004, Contributions to nephrology.

[62]  Mark D Johnson,et al.  Proteomic Analysis in the Neurosciences* , 2002, Molecular & Cellular Proteomics.

[63]  L. Gesualdo,et al.  Urinary IL-6/EGF ratio: a useful prognostic marker for the progression of renal damage in IgA nephropathy. , 1996, Kidney international.

[64]  Y. Kusunoki.  [Terminal complement complex (TTC) levels in plasma and urine from glomerular diseases: enzyme-linked immunosorbent assay (ELISA) using monoclonal antibody against neoantigens of TCC]. , 1990, [Hokkaido igaku zasshi] The Hokkaido journal of medical science.

[65]  Y. Tsukada,et al.  Urine glycosaminoglycans and heparan sulfate excretions in adult patients with glomerular diseases. , 1993, Clinical nephrology.

[66]  J. Klein,et al.  Overview of proteomics. , 2004, Contributions to nephrology.

[67]  B. Julian,et al.  Progress in the pathogenesis of IgA nephropathy. , 1999, Advances in nephrology from the Necker Hospital.

[68]  F. Fervenza.  Henoch‐Schönlein purpura nephritis , 2003, International journal of dermatology.

[69]  W. Kolch,et al.  Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface-enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometry. , 2004, Rapid communications in mass spectrometry : RCM.

[70]  B. Julian,et al.  Progress in Molecular and Genetic Studies of IgA Nephropathy , 2001, Journal of Clinical Immunology.

[71]  Stephen M Hewitt,et al.  Discovery of protein biomarkers for renal diseases. , 2004, Journal of the American Society of Nephrology : JASN.

[72]  R. Coppo,et al.  Removal systems of immunoglobulin A and immunoglobulin A containing complexes in IgA nephropathy and cirrhosis patients. The role of asialoglycoprotein receptors. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[73]  Erika Check,et al.  Proteomics and cancer: Running before we can walk? , 2004, Nature.

[74]  J. Yao,et al.  Adhesion molecules in the glomerular mesangium. , 1997, Kidney international.

[75]  R. Aebersold,et al.  Mass spectrometry in proteomics. , 2001, Chemical reviews.

[76]  M. J. Chalmers,et al.  Clinical proteomics: a question of technology. , 2004, Rapid communications in mass spectrometry : RCM.

[77]  H. Mischak,et al.  High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS , 2006, Proteomics.

[78]  B. Julian,et al.  IgA nephropathy: an update , 2004, Current opinion in nephrology and hypertension.

[79]  Y. Hiki,et al.  Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. , 2001, Kidney international.

[80]  A. Woodroffe,et al.  Recurrent mesangial IgA nephritis following renal transplantation. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[81]  J. Barratt,et al.  IgA nephropathy. , 2014, British journal of hospital medicine.

[82]  D. Topalov,et al.  [Serum and urinary interleukin-6 levels in patients with primary glomerulonephritis]. , 1996, Srpski arhiv za celokupno lekarstvo.

[83]  J. Feehally,et al.  Pathogenesis of IgA nephropathy. , 1999, Annales de medecine interne.

[84]  J. Couchman,et al.  Glomerular matrix: synthesis, turnover and role in mesangial expansion. , 1994, Kidney international.

[85]  Harald Mischak,et al.  Advances in urinary proteome analysis and biomarker discovery. , 2007, Journal of the American Society of Nephrology : JASN.

[86]  Y. Tomino,et al.  Urinary levels of interleukin‐8 (IL‐8) and disease activity in patients with IgA nephropathy , 2001, Journal of clinical laboratory analysis.

[87]  M. Haas,et al.  Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.